339 related articles for article (PubMed ID: 26336167)
1. Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response.
Hamede RK; Pearse AM; Swift K; Barmuta LA; Murchison EP; Jones ME
Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26336167
[TBL] [Abstract][Full Text] [Related]
2. Biting injuries and transmission of Tasmanian devil facial tumour disease.
Hamede RK; McCallum H; Jones M
J Anim Ecol; 2013 Jan; 82(1):182-90. PubMed ID: 22943286
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil.
Bender HS; Marshall Graves JA; Deakin JE
Annu Rev Anim Biosci; 2014 Feb; 2():165-87. PubMed ID: 25384139
[TBL] [Abstract][Full Text] [Related]
4. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population.
Pearse AM; Swift K; Hodson P; Hua B; McCallum H; Pyecroft S; Taylor R; Eldridge MD; Belov K
Cancer Genet; 2012 Mar; 205(3):101-12. PubMed ID: 22469509
[TBL] [Abstract][Full Text] [Related]
5. Reduced effect of Tasmanian devil facial tumor disease at the disease front.
Hamede R; Lachish S; Belov K; Woods G; Kreiss A; Pearse AM; Lazenby B; Jones M; McCallum H
Conserv Biol; 2012 Feb; 26(1):124-34. PubMed ID: 21978020
[TBL] [Abstract][Full Text] [Related]
6. Devil Facial Tumor Disease.
Pye RJ; Woods GM; Kreiss A
Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
[TBL] [Abstract][Full Text] [Related]
8. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).
Ujvari B; Hamede R; Peck S; Pemberton D; Jones M; Belov K; Madsen T
Sci Rep; 2016 Apr; 6():25093. PubMed ID: 27126067
[TBL] [Abstract][Full Text] [Related]
9. Immunology of a Transmissible Cancer Spreading among Tasmanian Devils.
Woods GM; Howson LJ; Brown GK; Tovar C; Kreiss A; Corcoran LM; Lyons AB
J Immunol; 2015 Jul; 195(1):23-9. PubMed ID: 26092814
[TBL] [Abstract][Full Text] [Related]
10. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
Patchett AL; Flies AS; Lyons AB; Woods GM
Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
[TBL] [Abstract][Full Text] [Related]
11. Transmissible cancer influences immune gene expression in an endangered marsupial, the Tasmanian devil (Sarcophilus harrisii).
Raven N; Klaassen M; Madsen T; Thomas F; Hamede RK; Ujvari B
Mol Ecol; 2022 Apr; 31(8):2293-2311. PubMed ID: 35202488
[TBL] [Abstract][Full Text] [Related]
12. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
[TBL] [Abstract][Full Text] [Related]
13. The impact of disease on the survival and population growth rate of the Tasmanian devil.
Lachish S; Jones M; McCallum H
J Anim Ecol; 2007 Sep; 76(5):926-36. PubMed ID: 17714271
[TBL] [Abstract][Full Text] [Related]
14. Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer.
Peel E; Belov K
Mamm Genome; 2018 Dec; 29(11-12):731-738. PubMed ID: 30225648
[TBL] [Abstract][Full Text] [Related]
15. Comparative landscape genetics reveals differential effects of environment on host and pathogen genetic structure in Tasmanian devils (Sarcophilus harrisii) and their transmissible tumour.
Kozakiewicz CP; Ricci L; Patton AH; Stahlke AR; Hendricks SA; Margres MJ; Ruiz-Aravena M; Hamilton DG; Hamede R; McCallum H; Jones ME; Hohenlohe PA; Storfer A
Mol Ecol; 2020 Sep; 29(17):3217-3233. PubMed ID: 32682353
[TBL] [Abstract][Full Text] [Related]
16. Transmissible cancer and longitudinal telomere dynamics in Tasmanian devils (Sarcophilus harrisii).
Madsen T; Klaassen M; Raven N; Dujon AM; Jennings G; Thomas F; Hamede R; Ujvari B
Mol Ecol; 2022 Dec; 31(24):6531-6540. PubMed ID: 36205590
[TBL] [Abstract][Full Text] [Related]
17. Evidence that disease-induced population decline changes genetic structure and alters dispersal patterns in the Tasmanian devil.
Lachish S; Miller KJ; Storfer A; Goldizen AW; Jones ME
Heredity (Edinb); 2011 Jan; 106(1):172-82. PubMed ID: 20216571
[TBL] [Abstract][Full Text] [Related]
18. Sex bias in ability to cope with cancer: Tasmanian devils and facial tumour disease.
Ruiz-Aravena M; Jones ME; Carver S; Estay S; Espejo C; Storfer A; Hamede RK
Proc Biol Sci; 2018 Nov; 285(1891):. PubMed ID: 30464069
[TBL] [Abstract][Full Text] [Related]
19. A comparative genomics approach to understanding transmissible cancer in Tasmanian devils.
Deakin JE; Belov K
Annu Rev Genomics Hum Genet; 2012; 13():207-22. PubMed ID: 22657390
[TBL] [Abstract][Full Text] [Related]
20. Trophic cascades following the disease-induced decline of an apex predator, the Tasmanian devil.
Hollings T; Jones M; Mooney N; McCallum H
Conserv Biol; 2014 Feb; 28(1):63-75. PubMed ID: 24024987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
